LLSC Corporate News


Read all The Leukemia & Lymphoma Society of Canada's press releases

Media Contact

Have media inquiries? Contact us between 9 a.m. and 5 p.m. ET, Monday through Friday.

Regina Kulikowski
Vice President Stakeholder Engagement


News Releases

Surviving Quarantine by Rachele Chaar

    This article was written by Rachele Chaar, a bone marrow transplant and Hodgkin lymphoma survivor.    
Surviving Quarantine     Following the surge in COVID-19 cases, many provinces across Canada have declared a state emergency. In order to help contain the pandemic and flatten the curve, we’ve been asked to stay home as much as possible a...

Ten Self-Care Tips to Cope with Isolation and Stress

Whether you are self-quarantining or practicing social distancing, we all are adjusting to a new normal amid the coronavirus disease (COVID-19) pandemic. Everyone reacts differently to stressful situations. As a person diagnosed with a blood cancer, you might be experiencing feelings of isolation, uncertainty and anxiety. As a caregiver, you might be feeling overwhelmed with navigating your loved one’s care while l...

More COVID-19 Questions and Answers

The ways we need to live our lives in the midst of this global COVID-19 pandemic is changing daily as federal and provincial governments ask us to hunker down, schools and businesses are shutting down or moving to virtual settings. We continue to hear every day from Canadians affected by blood cancers about how they should navigate their treatment and care in this confusing time.  You asked and we’re respon...

The Coronavirus (Covid-19) and You...

The Leukemia & Lymphoma Society of Canada is closely monitoring the developments on the coronavirus disease (COVID-19) outbreak and how it might impact Canadians affected by blood cancers. Visit our COVID-19 Resource Center Some people in treatment may be worried about the supply of therapeutic drugs (such as Imbruvica or Ibrutinib) produced in China. Its manufacturer Pharmacyclics is closely monitoring the...